CLINICAL_TRIALS
trial_result
· 2025-04-11
Clinical Trial Update: A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant [NA]
Summary
A completed clinical trial evaluating curcumin (Soloways) in patients with inflammatory bowel disease who are homozygous for the IL-10 variant has been document…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: S.LAB (SOLOWAYS) | Conditions: Inflamatory Bowel Disease | NA | Status: COMPLETED